EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single-cell transcriptomics reveals a compartmentalized antiviral interferon response in the nasal epithelium of mice

Xuefei Wang, Meng Dong, Xinchao Wu, Daniel Schnepf, Julia Thiel, Wenfei Sun, Christian Wolfrum, Sisi Li, Wenfei Jin iD, Peter Staeheli iD, Liang Ye iD

Journal of Virology · 2025

DOI: 10.1128/jvi.01413-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2025. Verfasst von Xuefei Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, International Cancer Center, Shenzhen University Medical School, Shenzhen, China. Hauptthemen laut MEDLINE: Nasal Mucosa, Transcriptome, Interferons, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China (NSFC), Shenzhen Medical Research Fund, Guangdong Provincial Pearl River Talents Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type III interferons (IFNs) primarily act on epithelial cells and protect against virus infection of the mucosa, whereas type I IFNs act more systemically. To date, it has been unknown which epithelial subtypes in the upper airways, the primary site for initial infection for most respiratory viruses, primarily rely on type III IFN or type I IFNs for antiviral protection. To address this question, we performed a single-cell transcriptomics analysis of the epithelial IFN-mediated response focusing on the upper airways of mice. This work identified nine distinct cell types derived from the olfactory epithelium and thirteen distinct cell types from the respiratory epithelium. Interestingly, type I IFNs induced a stronger antiviral transcriptional response than type III IFN in respiratory epithelial cells, whereas in olfactory epithelial cells, including sustentacular (SUS) and Bowman’s gland cells (BGC), type III IFN was more dominant compared to type I IFN. SUS and BGC, which provide structural support and maintain the integrity of olfactory sensory neurons, were highly susceptible to infection with a mouse-adapted variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 MA20) but were protected against infection if the animals were prophylactically treated with type III IFN. These findings demonstrate a high degree of cell type heterogeneity in terms of interferon-mediated antiviral responses and reveal a potent role for type III IFNs in protecting the olfactory epithelium. IMPORTANCE SARS-CoV-2 infects SUS and BGC in the olfactory epithelium, causing an impairment of structural support and integrity of olfactory sensory neurons that can result in severe olfactory dysfunctions. We observed an unexpected compartmentalization of the IFN-mediated transcriptional response within the airway epithelium, and we found that olfactory epithelial cells preferentially respond to type III IFN, which resulted in robust antiviral protection of SUS and BGC. Given the proximity of the olfactory epithelium to the central nervous system, we hypothesize that evolution favored a type III IFN-biased antiviral immune response in this tissue to limit inflammatory responses in the brain. Cell type-specific antiviral responses in the upper airways, triggered by the different types of IFNs, should be investigated in more detail and carefully taken into consideration during the development of IFN-based antivirals for clinical use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nasal MucosaTranscriptomeInterferonsSARS-CoV-2Antiviral AgentsCOVID-19AnimalsMiceSingle-Cell AnalysisInterferon Type IOlfactory MucosaEpithelial CellsMice, Inbred C57BLGene Expression ProfilingInterferon LambdaRespiratory Mucosa

Stichwörter der Autor:innen

SARS-CoV-2interferonsrespiratory tract

Substanzen

InterferonsInterferon Type IAntiviral AgentsInterferon Lambda

Autor:innen und Institutionen

  • Department of Immunology, International Cancer Center, Shenzhen University Medical School, Shenzhen, China.
  • Shenzhen Key Laboratory of Gene Regulation, Department of Systems Biology School of Life Sciences, Southern University of Science and Technology, Shenzhen, China.
  • Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tübingen, Stuttgart, Germany.
  • Institute of Virology, Medical Center University of Freiburg, Freiburg, Germany.
  • Immunoregulation Laboratory, The Francis Crick Institute, London, United Kingdom.
  • Institute of Food, Nutrition and Health, ETH Zurich, Schwerzenbach, Switzerland.

ORCID-Profile: Wenfei Jin, Peter Staeheli, Liang Ye

Förderung

  • National Natural Science Foundation of China (NSFC)
  • Shenzhen Medical Research Fund
  • Guangdong Provincial Pearl River Talents Program
  • Shenzhen Peacock Plan Team
  • Research Team Cultivation Program of Shenzhen University
  • Berthold Leibinger Stiftung (Berthold Leibinger Foundation)
  • Robert Bosch Stiftung (RBS)

Zitieren

APA

Wang, X., Dong, M., Wu, X., Schnepf, D., Thiel, J., Sun, W., Wolfrum, C., Li, S., Jin, W., Staeheli, P., & Ye, L. (2025). Single-cell transcriptomics reveals a compartmentalized antiviral interferon response in the nasal epithelium of mice. Journal of Virology. https://doi.org/10.1128/jvi.01413-24

Vancouver

Wang X, Dong M, Wu X, Schnepf D, Thiel J, Sun W, et al. Single-cell transcriptomics reveals a compartmentalized antiviral interferon response in the nasal epithelium of mice. Journal of Virology. 2025. doi:10.1128/jvi.01413-24

BibTeX
@article{Wang2025,
  author = {Wang, Xuefei and Dong, Meng and Wu, Xinchao and Schnepf, Daniel and Thiel, Julia and Sun, Wenfei and Wolfrum, Christian and Li, Sisi and Jin, Wenfei and Staeheli, Peter and Ye, Liang},
  title = {Single-cell transcriptomics reveals a compartmentalized antiviral interferon response in the nasal epithelium of mice},
  journal = {Journal of Virology},
  year = {2025},
  doi = {10.1128/jvi.01413-24}
}
Kostenlos starten →